TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: AUDs and PTSD Treatment for Victims of Partner Violence
Brief Summary: The goal of this study is to evaluate a psychotherapy for PTSD and substance use disorders among women who have experienced domestic violence. The hypothesis is that women who receive present-focused, integrated treatment will have greater PTSD symptom reduction and have less substance use after treatment than women in the control condition who will receive supportive therapy based on a 12-step approach.


Options:
A: Arm Label: Mental health treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Improving AIDS Care after Trauma (ImpACT) | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Improving AIDS Care after Trauma (ImpACT); Assigned to Arm(s): Mental health treatment
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Prolonged Exposure | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Present Centered Therapy | Intervention Type: PROCEDURE; Name: Prolonged Exposure; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Present Centered Therapy; Assigned to Arm(s): 2
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated psychotherapy for PTSD and substance use | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 12-step based supportive therapy | Intervention Type: BEHAVIORAL; Name: Integrated psychotherapy for PTSD and substance use; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: 12-step based supportive therapy; Assigned to Arm(s): 2
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Cognitive Behavioral Treatment for Insomnia (CBT-I) | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cognitive Behavioral Treatment for Insomnia (CBT-I); Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicentre Randomised Controlled Trial of HELP (Heat Loss Prevention) in the Delivery Room
Brief Summary: Does polyethylene occlusive wrap applied immediately after delivery to infants born at less than 28 weeks gestation decrease all-cause mortality measured at discharge compared with the standard of care as determined by the Neonatal Resuscitation Program guidelines (i.e. drying under radiant heat)?


Options:
A: Intervention Type: BEHAVIORAL; Name: Newborn Thermal Care Practice; Assigned to Arm(s): N/A
B: Arm Label: Resuscitation with plastic bag; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Resuscitation and post resuscitation care with plastic bag | Arm Label: Standard resuscitation- no plastic bag; Type: SHAM_COMPARATOR; Interventions: Procedure: Resuscitation- no plastic bag for temperature regulation | Intervention Type: PROCEDURE; Name: Resuscitation and post resuscitation care with plastic bag; Assigned to Arm(s): Resuscitation with plastic bag | Intervention Type: PROCEDURE; Name: Resuscitation- no plastic bag for temperature regulation; Assigned to Arm(s): Standard resuscitation- no plastic bag
C: Arm Label: Total body polyethylene wrap (body plus head); Type: EXPERIMENTAL; Interventions: Device: Polyethylene wrap | Arm Label: Polyethylene wrap (body); Type: ACTIVE_COMPARATOR; Interventions: Device: Polyethylene wrap | Intervention Type: DEVICE; Name: Polyethylene wrap; Assigned to Arm(s): Total body polyethylene wrap (body plus head) | Intervention Type: DEVICE; Name: Polyethylene wrap; Assigned to Arm(s): Polyethylene wrap (body)
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: Polyethylene occlusive skin wrap | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Polyethylene occlusive skin wrap; Assigned to Arm(s): 1

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Proactive Tobacco Treatment for Diverse Veteran Smokers
Brief Summary: Tobacco use is the leading cause of premature death in the United States and disproportionately affects Veterans and certain racial/ethnic minority groups. Most smokers are interested in quitting; however, current tobacco use treatment approaches are reactive and require smokers to initiate treatment or depend on the provider to initiate smoking cessation care. As a result, most smokers do not receive comprehensive, evidence-based treatment for tobacco use that includes intensive behavioral counseling along with pharmacotherapy. Proactive tobacco treatment integrates population-based treatment (i.e., proactive outreach) and individual-level treatment (i.e., smoking cessation counseling and pharmacotherapy) to address both patient and provider barriers to comprehensive care.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: motivational counseling | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: placebo | Intervention Type: BEHAVIORAL; Name: motivational counseling; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: placebo; Assigned to Arm(s): 2
B: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Proactive Care; Type: EXPERIMENTAL; Interventions: Behavioral: Proactive Outreach with choice of telephone or in-person smoking cessation services | Intervention Type: BEHAVIORAL; Name: Proactive Outreach with choice of telephone or in-person smoking cessation services; Assigned to Arm(s): Proactive Care
C: Intervention Type: BEHAVIORAL; Name: Smoking cessation counseling delivered by telephone; Assigned to Arm(s): N/A
D: Arm Label: Life Style Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: IVR intervention | Arm Label: Life Counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: IVR control | Intervention Type: BEHAVIORAL; Name: IVR intervention; Assigned to Arm(s): Life Style Counseling | Intervention Type: BEHAVIORAL; Name: IVR control; Assigned to Arm(s): Life Counseling

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: CARdiorenal REScue Study in Acute Decompensated Heart Failure: CARRESS
Brief Summary: Heart failure is a serious condition in which the heart's ability to pump blood through the body is impaired, often making a person feel weak or fatigued. When a person's condition worsens to the point of hospitalization, that person is said to have acute decompensated heart failure (ADHF). Abnormal kidney function in association with cardiac distress, known as cardiorenal syndrome, is a common complication of heart failure and causes further medical problems and need for hospitalization. While there are various effective treatments for heart failure, more research is needed to determine the best treatment for targeting both ADHF and cardiorenal syndrome. This study will compare the safety and effectiveness of ultrafiltration versus standard medical drug therapy in improving renal function and relieving fluid buildup in people hospitalized with ADHF and cardiorenal syndrome.


Options:
A: Arm Label: Stepped pharmacologic care; Type: ACTIVE_COMPARATOR; Interventions: Drug: Stepped pharmacologic care | Arm Label: Ultrafiltration; Type: EXPERIMENTAL; Interventions: Device: Ultrafiltration | Intervention Type: DRUG; Name: Stepped pharmacologic care; Assigned to Arm(s): Stepped pharmacologic care | Intervention Type: DEVICE; Name: Ultrafiltration; Assigned to Arm(s): Ultrafiltration
B: Arm Label: Continuous Furosemide Infusion; Type: N/A; Interventions: Drug: Continuous Furosemide Infusion | Arm Label: Intermittent Furosemide Infusion; Type: N/A; Interventions: Drug: Intermittent Furosemide Infusion | Intervention Type: DRUG; Name: Continuous Furosemide Infusion; Assigned to Arm(s): Continuous Furosemide Infusion | Intervention Type: DRUG; Name: Intermittent Furosemide Infusion; Assigned to Arm(s): Intermittent Furosemide Infusion
C: Intervention Type: DRUG; Name: Beta-blockers including Carvedilol; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: ACE inhibitors; Assigned to Arm(s): N/A
D: Arm Label: Ultrafiltration; Type: EXPERIMENTAL; Interventions: Procedure: ultrafiltration | Arm Label: Usual treatment; Type: ACTIVE_COMPARATOR; Interventions: Procedure: ultrafiltration | Intervention Type: PROCEDURE; Name: ultrafiltration; Assigned to Arm(s): Ultrafiltration, Usual treatment

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Studying of Acupuncture for Bell's Palsy According to Different Stages
Brief Summary: The purpose of this trial will certify the efficacy of using staging acupuncture and moxibustion to treat Bell's Palsy


Options:
A: Arm Label: 1; Type: SHAM_COMPARATOR; Interventions: Device: Acupuncture | Intervention Type: DEVICE; Name: Acupuncture; Assigned to Arm(s): 1
B: Arm Label: group 1; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 2; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 3; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 4; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: group 5; Type: SHAM_COMPARATOR; Interventions: Other: acupuncture | Arm Label: group 6; Type: ACTIVE_COMPARATOR; Interventions: Drug: Itopride | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): group 1, group 2, group 3, group 4, group 5 | Intervention Type: DRUG; Name: Itopride; Assigned to Arm(s): group 6
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Arm Label: B; Type: EXPERIMENTAL; Interventions: Other: acupuncture and moxibustion | Arm Label: C; Type: EXPERIMENTAL; Interventions: Other: electroacupuncture | Arm Label: D; Type: EXPERIMENTAL; Interventions: Other: acupuncture along yangming tendons | Arm Label: E; Type: EXPERIMENTAL; Interventions: Other: acupuncture | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): A | Intervention Type: OTHER; Name: acupuncture and moxibustion; Assigned to Arm(s): B | Intervention Type: OTHER; Name: electroacupuncture; Assigned to Arm(s): C | Intervention Type: OTHER; Name: acupuncture along yangming tendons; Assigned to Arm(s): D | Intervention Type: OTHER; Name: acupuncture; Assigned to Arm(s): E
D: Arm Label: acupuncture; Type: EXPERIMENTAL; Interventions: Other: acupuncture, injection | Arm Label: injections of diclofenac; Type: ACTIVE_COMPARATOR; Interventions: Other: acupuncture, injection | Intervention Type: OTHER; Name: acupuncture, injection; Assigned to Arm(s): acupuncture, injections of diclofenac

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene)
Brief Summary: Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is often caused by cigarette smoking. The purpose of this study is to evaluate whether certain genetic factors predispose some smokers to develop COPD more than others.


Options:
A: Intervention Type: DRUG; Name: tiotropium; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): N/A
B: Arm Label: Smokers without COPD; Type: N/A; Interventions: N/A | Arm Label: Severe COPD; Type: N/A; Interventions: N/A | Arm Label: Mild/Moderate COPD; Type: N/A; Interventions: N/A | Arm Label: Non-smokers; Type: N/A; Interventions: N/A
C: Arm Label: COPD subjects; Type: N/A; Interventions: Other: Novel endpoint determination | Arm Label: Smoker controls; Type: N/A; Interventions: Other: Novel endpoint determination | Arm Label: Non-smoker controls; Type: N/A; Interventions: Other: Novel endpoint determination | Intervention Type: OTHER; Name: Novel endpoint determination; Assigned to Arm(s): COPD subjects, Non-smoker controls, Smoker controls
D: Arm Label: NHW COPD Participants; Type: N/A; Interventions: N/A | Arm Label: NHW Control Group; Type: N/A; Interventions: N/A | Arm Label: AA COPD Participants; Type: N/A; Interventions: N/A | Arm Label: AA Control Group; Type: N/A; Interventions: N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Statins on Skeletal Muscle Function
Brief Summary: Statins are a group of medications that are used to lower cholesterol levels. Although serious side effects are rare, some people taking statins experience muscle pain or weakness. This study will evaluate the number of people who experience mild muscle complaints and will determine the effect of statins on skeletal muscle strength, endurance, and aerobic exercise performance.


Options:
A: Arm Label: Atorvastatin; Type: EXPERIMENTAL; Interventions: Drug: Lipitor | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Lipitor; Assigned to Arm(s): Atorvastatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): N/A
C: Arm Label: Cohort 1; Type: EXPERIMENTAL; Interventions: Drug: REGN727, Drug: Placebo | Arm Label: Cohort 2; Type: EXPERIMENTAL; Interventions: Drug: REGN727, Drug: Placebo | Arm Label: Cohort 3; Type: EXPERIMENTAL; Interventions: Drug: REGN727, Drug: Placebo | Arm Label: Cohort 4; Type: EXPERIMENTAL; Interventions: Drug: REGN727, Drug: Placebo | Intervention Type: DRUG; Name: REGN727; Assigned to Arm(s): Cohort 1, Cohort 2, Cohort 3, Cohort 4 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Cohort 1, Cohort 2, Cohort 3, Cohort 4
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Atorvastatin | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective, Randomized, Multi-Center Trial of Initial Trophic Enteral Feeding Followed by Advancement to Full-Calorie Enteral Feeding vs. Early Advancement to Full-Calorie Enteral Feeding in Patients With Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS) and Prospective, Randomized, Blinded, Placebo-Controlled, Multi-Center Trial of Omega-3 Fatty Acid, Gamma-Linolenic Acid, and Anti-Oxidant Supplementation in the Management of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS)
Brief Summary: Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) are medical conditions that occur when there is severe inflammation and increased fluids in both lungs, making it difficult for the lungs to function properly. Hospital treatment for a person with ALI/ARDS often includes the use of a breathing machine, or ventilator, until the person is able to breathe without assistance. Initiating proper nutrition through a feeding tube early in a person's hospital stay may help to improve recovery, but the optimal timing, composition, and amount of feeding treatments are unknown. This study will evaluate whether early or delayed full-calorie feeding through a feeding tube is more effective in reducing recovery time and increasing survival rates in people with ALI/ARDS. The study will also determine whether supplementing the feedings with omega-3 fatty acids and antioxidants benefits people with ALI/ARDS.


Options:
A: Arm Label: SPN group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: SPN | Arm Label: Control gr; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: SPN; Assigned to Arm(s): SPN group
B: Intervention Type: DRUG; Name: low calorie, low nitrogen parenteral nutrition for patient with NRS score 3; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: trophic enteral feeds | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: trophic enteral feeds | Intervention Type: BEHAVIORAL; Name: trophic enteral feeds; Assigned to Arm(s): 1, 2
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Minimal (Trophic) Feeding, Dietary Supplement: Omega-3 Fatty Acids and Antioxidant Supplements | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Full Feeding, Dietary Supplement: Omega-3 Fatty Acids and Antioxidant Supplements | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Minimal (Trophic) Feeding, Dietary Supplement: Placebo | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Full Feeding, Dietary Supplement: Placebo | Intervention Type: BEHAVIORAL; Name: Minimal (Trophic) Feeding; Assigned to Arm(s): 1, 3 | Intervention Type: BEHAVIORAL; Name: Full Feeding; Assigned to Arm(s): 2, 4 | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega-3 Fatty Acids and Antioxidant Supplements; Assigned to Arm(s): 1, 2 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): 3, 4

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Macronutrient Composition of Diet and Risk Factors for Cardiovascular Disease
Brief Summary: The objective of this trial is to examine the long-term effects of a diet low in carbohydrates, as compared to one low in fat, on cardiovascular disease risk factors, including blood pressure (BP), body weight and composition, serum lipids, plasma glucose, insulin, adipocytokines (adiponectin, leptin, resistin), and C-reactive protein (CRP) among obese adults.

The investigators will test the following hypotheses:

Hypothesis 1: Compared to a low fat diet, a diet low in carbohydrates will reduce systolic and diastolic BP over 12 months; Hypothesis 2: Compared to a low fat diet, a diet low in carbohydrates will reduce body weight, total percent body fat, and waist circumference over 12 months; Hypothesis 3: Compared to a low fat diet, a diet low in carbohydrates will reduce serum levels of LDL-cholesterol and triglycerides and increase serum levels of HDL-cholesterol over 12 months; Hypothesis 4: Compared to a low fat diet, a diet low in carbohydrates will reduce plasma levels of glucose and insulin levels over 12 months; and Hypothesis 5: Compared to a low fat diet, a diet low in carbohydrates will reduce plasma levels of leptin, resistin, and CRP and increase plasma levels of adiponectin over 12 months.


Options:
A: Arm Label: Full fat dairy group; Type: EXPERIMENTAL; Interventions: Other: Full fat dairy | Arm Label: Low fat dairy group; Type: EXPERIMENTAL; Interventions: Other: Low fat dairy | Arm Label: Control group; Type: OTHER; Interventions: Other: Control | Intervention Type: OTHER; Name: Full fat dairy; Assigned to Arm(s): Full fat dairy group | Intervention Type: OTHER; Name: Low fat dairy; Assigned to Arm(s): Low fat dairy group | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control group
B: Arm Label: Low Fat Diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low Fat Diet | Arm Label: Mediterranean Diet; Type: EXPERIMENTAL; Interventions: Behavioral: Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: Mediterranean Diet; Assigned to Arm(s): Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: Low Fat Diet; Assigned to Arm(s): Low Fat Diet
C: Intervention Type: BEHAVIORAL; Name: dietary intervention; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: low carbohydrate diet | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: low fat diet | Intervention Type: BEHAVIORAL; Name: low carbohydrate diet; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: low fat diet; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Macronutrient Composition of Diet and Risk Factors for Cardiovascular Disease
Brief Summary: The objective of this trial is to examine the long-term effects of a diet low in carbohydrates, as compared to one low in fat, on cardiovascular disease risk factors, including blood pressure (BP), body weight and composition, serum lipids, plasma glucose, insulin, adipocytokines (adiponectin, leptin, resistin), and C-reactive protein (CRP) among obese adults.

The investigators will test the following hypotheses:

Hypothesis 1: Compared to a low fat diet, a diet low in carbohydrates will reduce systolic and diastolic BP over 12 months; Hypothesis 2: Compared to a low fat diet, a diet low in carbohydrates will reduce body weight, total percent body fat, and waist circumference over 12 months; Hypothesis 3: Compared to a low fat diet, a diet low in carbohydrates will reduce serum levels of LDL-cholesterol and triglycerides and increase serum levels of HDL-cholesterol over 12 months; Hypothesis 4: Compared to a low fat diet, a diet low in carbohydrates will reduce plasma levels of glucose and insulin levels over 12 months; and Hypothesis 5: Compared to a low fat diet, a diet low in carbohydrates will reduce plasma levels of leptin, resistin, and CRP and increase plasma levels of adiponectin over 12 months.


Options:
A: Intervention Type: BEHAVIORAL; Name: dietary intervention; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: low carbohydrate diet | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: low fat diet | Intervention Type: BEHAVIORAL; Name: low carbohydrate diet; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: low fat diet; Assigned to Arm(s): 2
C: Intervention Type: BEHAVIORAL; Name: Mono Unsaturated Fatty Acids in Obesity; Assigned to Arm(s): N/A
D: Arm Label: Probiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotics | Arm Label: Probiotics + Dietary counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and probiotics | Arm Label: Dietary counseling + placebo; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and placebo | Arm Label: Prebiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Prebiotics | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo capsules | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary counselling and placebo; Assigned to Arm(s): Dietary counseling + placebo | Intervention Type: BEHAVIORAL; Name: Dietary counselling and probiotics; Assigned to Arm(s): Probiotics + Dietary counseling | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo capsules; Assigned to Arm(s): Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotics; Assigned to Arm(s): Probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Prebiotics; Assigned to Arm(s): Prebiotics

Answer: B